MSC-EVs and Brain–Lung Crosstalk in Subarachnoid Hemorrhage: Mechanisms and Therapeutic Prospects

Subarachnoid hemorrhage (SAH) is frequently complicated by acute lung injury (ALI), forming a pathological brain–lung interaction known as the brain–lung axis. Growing evidence suggests that neuroinflammation, autonomic dysregulation, immune alterations, and neuroendocrine signaling collectively contribute to this bidirectional injury process. Mesenchymal stem cell–derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutic agents, as they carry diverse bioactive cargo, including RNAs, proteins, lipids, and mitochondrial components, which can modulate inflammatory responses and promote tissue repair. In this review, we summarize current evidence regarding the role of MSC-EVs in both SAH and ALI, and we discuss how their molecular cargo may influence brain–lung interactions. We pay particular attention to RNA-mediated signaling pathways, mitochondrial transfer, and EVs-associated proteins that regulate neuroinflammation, apoptosis, and barrier integrity in both the brain and lung. We also highlight mechanisms that may contribute to SAH-associated lung injury, including catecholamine surge, systemic inflammatory responses, and immune dysregulation that occur following early brain injury. By integrating findings from studies of SAH, ALI, and extracellular vesicle biology, this review outlines a conceptual framework for understanding how MSC-EVs may modulate the brain–lung axis and discusses their potential as a dual-organ therapeutic strategy for treating SAH-associated ALI. After SAH, inflammatory and neuroendocrine signals drive brain–lung crosstalk, leading to BBB disruption and epithelial damage in the brain and propagating injury in the lung, manifesting as pneumonia and pulmonary edema. MSC-derived extracellular vesicles (MSC-EVs) transport bioactive cargo (including miRNAs and proteins/lipids) to target cells, modulating signaling pathways to reduce neuroinflammation and apoptosis and promote BBB repair, while also suppressing pulmonary inflammation and supporting epithelial recovery via inhibitory effects on key miRNA-linked pathways

Authors

Institutions

Publication Details

Journal
Translational Stroke Research
Published
2026-11-18
DOI
https://doi.org/10.1007/s12975-026-01515-9
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

MSC-EVs and Brain–Lung Crosstalk in Subarachnoid Hemorrhage: Mechanisms and Therapeutic Prospects

Yizhou Li, Zhipeng Xiao, Hao Wan, Jianbin Hu et al.
1 links
Translational Stroke Research
Extracellular vesicles in disease
article

MSC-EVs and Brain–Lung Crosstalk in Subarachnoid Hemorrhage: Mechanisms and Therapeutic Prospects

Yizhou Li, Zhipeng Xiao, Hao Wan, Jianbin Hu, Fanjian Li
article en

Abstract

Subarachnoid hemorrhage (SAH) is frequently complicated by acute lung injury (ALI), forming a pathological brain–lung interaction known as the brain–lung axis. Growing evidence suggests that neuroinflammation, autonomic dysregulation, immune alterations, and neuroendocrine signaling collectively contribute to this bidirectional injury process. Mesenchymal stem cell–derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutic agents, as they carry diverse bioactive cargo, including RNAs, proteins, lipids, and mitochondrial components, which can modulate inflammatory responses and promote tissue repair. In this review, we summarize current evidence regarding the role of MSC-EVs in both SAH and ALI, and we discuss how their molecular cargo may influence brain–lung interactions. We pay particular attention to RNA-mediated signaling pathways, mitochondrial transfer, and EVs-associated proteins that regulate neuroinflammation, apoptosis, and barrier integrity in both the brain and lung. We also highlight mechanisms that may contribute to SAH-associated lung injury, including catecholamine surge, systemic inflammatory responses, and immune dysregulation that occur following early brain injury. By integrating findings from studies of SAH, ALI, and extracellular vesicle biology, this review outlines a conceptual framework for understanding how MSC-EVs may modulate the brain–lung axis and discusses their potential as a dual-organ therapeutic strategy for treating SAH-associated ALI. After SAH, inflammatory and neuroendocrine signals drive brain–lung crosstalk, leading to BBB disruption and epithelial damage in the brain and propagating injury in the lung, manifesting as pneumonia and pulmonary edema. MSC-derived extracellular vesicles (MSC-EVs) transport bioactive cargo (including miRNAs and proteins/lipids) to target cells, modulating signaling pathways to reduce neuroinflammation and apoptosis and promote BBB repair, while also suppressing pulmonary inflammation and supporting epithelial recovery via inhibitory effects on key miRNA-linked pathways

Translational Stroke ResearchVol. 17(6)
Nanchang University (CN), First Affiliated Hospital of Jiangxi Medical College (CN), Third Affiliated Hospital of Nanchang University (CN), First Affiliated Hospital of Nanchang University (CN)
National Natural Science Foundation of China
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon